+1 347 708 0418
Neuromodulation Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Neuromodulation Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Deep Brain Stimulation (DBS)
Spinal Cord Stimulation (SCS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Gastric Electrical Stimulation (GES)
Segment by Application
Pain Management
Parkinsons Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
By Company
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Neuromodulation Devices Product Introduction
1.2 Market by Type
1.2.1 Global Neuromodulation Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Deep Brain Stimulation (DBS)
1.2.3 Spinal Cord Stimulation (SCS)
1.2.4 Vagus Nerve Stimulation (VNS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Gastric Electrical Stimulation (GES)
1.3 Market by Application
1.3.1 Global Neuromodulation Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pain Management
1.3.3 Parkinsons Disease
1.3.4 Urinary and Fecal Incontinence
1.3.5 Epilepsy
1.3.6 Gastroparesis
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neuromodulation Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Neuromodulation Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Neuromodulation Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Neuromodulation Devices Sales by Region
2.4.1 Global Neuromodulation Devices Sales by Region (2017-2022)
2.4.2 Global Sales Neuromodulation Devices by Region (2023-2028)
2.5 Global Neuromodulation Devices Revenue by Region
2.5.1 Global Neuromodulation Devices Revenue by Region (2017-2022)
2.5.2 Global Neuromodulation Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neuromodulation Devices Sales by Manufacturers
3.1.1 Global Top Neuromodulation Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Neuromodulation Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neuromodulation Devices in 2021
3.2 Global Neuromodulation Devices Revenue by Manufacturers
3.2.1 Global Neuromodulation Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Neuromodulation Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Neuromodulation Devices Revenue in 2021
3.3 Global Neuromodulation Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neuromodulation Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neuromodulation Devices Sales by Type
4.1.1 Global Neuromodulation Devices Historical Sales by Type (2017-2022)
4.1.2 Global Neuromodulation Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Neuromodulation Devices Sales Market Share by Type (2017-2028)
4.2 Global Neuromodulation Devices Revenue by Type
4.2.1 Global Neuromodulation Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Neuromodulation Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Neuromodulation Devices Revenue Market Share by Type (2017-2028)
4.3 Global Neuromodulation Devices Price by Type
4.3.1 Global Neuromodulation Devices Price by Type (2017-2022)
4.3.2 Global Neuromodulation Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Neuromodulation Devices Sales by Application
5.1.1 Global Neuromodulation Devices Historical Sales by Application (2017-2022)
5.1.2 Global Neuromodulation Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Neuromodulation Devices Sales Market Share by Application (2017-2028)
5.2 Global Neuromodulation Devices Revenue by Application
5.2.1 Global Neuromodulation Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Neuromodulation Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Neuromodulation Devices Revenue Market Share by Application (2017-2028)
5.3 Global Neuromodulation Devices Price by Application
5.3.1 Global Neuromodulation Devices Price by Application (2017-2022)
5.3.2 Global Neuromodulation Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Neuromodulation Devices Market Size by Type
6.1.1 North America Neuromodulation Devices Sales by Type (2017-2028)
6.1.2 North America Neuromodulation Devices Revenue by Type (2017-2028)
6.2 North America Neuromodulation Devices Market Size by Application
6.2.1 North America Neuromodulation Devices Sales by Application (2017-2028)
6.2.2 North America Neuromodulation Devices Revenue by Application (2017-2028)
6.3 North America Neuromodulation Devices Market Size by Country
6.3.1 North America Neuromodulation Devices Sales by Country (2017-2028)
6.3.2 North America Neuromodulation Devices Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Neuromodulation Devices Market Size by Type
7.1.1 Europe Neuromodulation Devices Sales by Type (2017-2028)
7.1.2 Europe Neuromodulation Devices Revenue by Type (2017-2028)
7.2 Europe Neuromodulation Devices Market Size by Application
7.2.1 Europe Neuromodulation Devices Sales by Application (2017-2028)
7.2.2 Europe Neuromodulation Devices Revenue by Application (2017-2028)
7.3 Europe Neuromodulation Devices Market Size by Country
7.3.1 Europe Neuromodulation Devices Sales by Country (2017-2028)
7.3.2 Europe Neuromodulation Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neuromodulation Devices Market Size by Type
8.1.1 Asia Pacific Neuromodulation Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Neuromodulation Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Neuromodulation Devices Market Size by Application
8.2.1 Asia Pacific Neuromodulation Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Neuromodulation Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Neuromodulation Devices Market Size by Region
8.3.1 Asia Pacific Neuromodulation Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Neuromodulation Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Neuromodulation Devices Market Size by Type
9.1.1 Latin America Neuromodulation Devices Sales by Type (2017-2028)
9.1.2 Latin America Neuromodulation Devices Revenue by Type (2017-2028)
9.2 Latin America Neuromodulation Devices Market Size by Application
9.2.1 Latin America Neuromodulation Devices Sales by Application (2017-2028)
9.2.2 Latin America Neuromodulation Devices Revenue by Application (2017-2028)
9.3 Latin America Neuromodulation Devices Market Size by Country
9.3.1 Latin America Neuromodulation Devices Sales by Country (2017-2028)
9.3.2 Latin America Neuromodulation Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neuromodulation Devices Market Size by Type
10.1.1 Middle East and Africa Neuromodulation Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Neuromodulation Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Neuromodulation Devices Market Size by Application
10.2.1 Middle East and Africa Neuromodulation Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Neuromodulation Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Neuromodulation Devices Market Size by Country
10.3.1 Middle East and Africa Neuromodulation Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Neuromodulation Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Medtronic Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Overview
11.2.3 Boston Scientific Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Boston Scientific Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boston Scientific Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 LivaNova
11.4.1 LivaNova Corporation Information
11.4.2 LivaNova Overview
11.4.3 LivaNova Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 LivaNova Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LivaNova Recent Developments
11.5 Nevro
11.5.1 Nevro Corporation Information
11.5.2 Nevro Overview
11.5.3 Nevro Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Nevro Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nevro Recent Developments
11.6 NeuroPace
11.6.1 NeuroPace Corporation Information
11.6.2 NeuroPace Overview
11.6.3 NeuroPace Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 NeuroPace Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 NeuroPace Recent Developments
11.7 Beijing Pins
11.7.1 Beijing Pins Corporation Information
11.7.2 Beijing Pins Overview
11.7.3 Beijing Pins Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Beijing Pins Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beijing Pins Recent Developments
11.8 Synapse Biomedical
11.8.1 Synapse Biomedical Corporation Information
11.8.2 Synapse Biomedical Overview
11.8.3 Synapse Biomedical Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Synapse Biomedical Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Synapse Biomedical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neuromodulation Devices Industry Chain Analysis
12.2 Neuromodulation Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neuromodulation Devices Production Mode & Process
12.4 Neuromodulation Devices Sales and Marketing
12.4.1 Neuromodulation Devices Sales Channels
12.4.2 Neuromodulation Devices Distributors
12.5 Neuromodulation Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neuromodulation Devices Industry Trends
13.2 Neuromodulation Devices Market Drivers
13.3 Neuromodulation Devices Market Challenges
13.4 Neuromodulation Devices Market Restraints
14 Key Findings in The Global Neuromodulation Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Neuromodulation Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Deep Brain Stimulation (DBS)
Table 3. Major Manufacturers of Spinal Cord Stimulation (SCS)
Table 4. Major Manufacturers of Vagus Nerve Stimulation (VNS)
Table 5. Major Manufacturers of Sacral Nerve Stimulation (SNS)
Table 6. Major Manufacturers of Gastric Electrical Stimulation (GES)
Table 7. Global Neuromodulation Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Neuromodulation Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Neuromodulation Devices Sales by Region (2017-2022) & (K Units)
Table 10. Global Neuromodulation Devices Sales Market Share by Region (2017-2022)
Table 11. Global Neuromodulation Devices Sales by Region (2023-2028) & (K Units)
Table 12. Global Neuromodulation Devices Sales Market Share by Region (2023-2028)
Table 13. Global Neuromodulation Devices Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Neuromodulation Devices Revenue Market Share by Region (2017-2022)
Table 15. Global Neuromodulation Devices Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Neuromodulation Devices Revenue Market Share by Region (2023-2028)
Table 17. Global Neuromodulation Devices Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Neuromodulation Devices Sales Share by Manufacturers (2017-2022)
Table 19. Global Neuromodulation Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Neuromodulation Devices Revenue Share by Manufacturers (2017-2022)
Table 21. Neuromodulation Devices Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Neuromodulation Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Neuromodulation Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices as of 2021)
Table 24. Neuromodulation Devices Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Neuromodulation Devices Product Offered
Table 26. Date of Manufacturers Enter into Neuromodulation Devices Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 29. Global Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 30. Global Neuromodulation Devices Sales Share by Type (2017-2022)
Table 31. Global Neuromodulation Devices Sales Share by Type (2023-2028)
Table 32. Global Neuromodulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Neuromodulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Neuromodulation Devices Revenue Share by Type (2017-2022)
Table 35. Global Neuromodulation Devices Revenue Share by Type (2023-2028)
Table 36. Neuromodulation Devices Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Neuromodulation Devices Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 39. Global Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 40. Global Neuromodulation Devices Sales Share by Application (2017-2022)
Table 41. Global Neuromodulation Devices Sales Share by Application (2023-2028)
Table 42. Global Neuromodulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Neuromodulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Neuromodulation Devices Revenue Share by Application (2017-2022)
Table 45. Global Neuromodulation Devices Revenue Share by Application (2023-2028)
Table 46. Neuromodulation Devices Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Neuromodulation Devices Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 49. North America Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 50. North America Neuromodulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Neuromodulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 53. North America Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 54. North America Neuromodulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Neuromodulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
Table 57. North America Neuromodulation Devices Sales by Country (2023-2028) & (K Units)
Table 58. North America Neuromodulation Devices Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Neuromodulation Devices Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 61. Europe Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 62. Europe Neuromodulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Neuromodulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 65. Europe Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 66. Europe Neuromodulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Neuromodulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
Table 69. Europe Neuromodulation Devices Sales by Country (2023-2028) & (K Units)
Table 70. Europe Neuromodulation Devices Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Neuromodulation Devices Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Neuromodulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Neuromodulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Neuromodulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Neuromodulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Neuromodulation Devices Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Neuromodulation Devices Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Neuromodulation Devices Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Neuromodulation Devices Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Neuromodulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Neuromodulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Neuromodulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Neuromodulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Neuromodulation Devices Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Neuromodulation Devices Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Neuromodulation Devices Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Neuromodulation Devices Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Neuromodulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Neuromodulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Neuromodulation Devices Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Neuromodulation Devices Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Neuromodulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Neuromodulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Neuromodulation Devices Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Neuromodulation Devices Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Neuromodulation Devices Revenue by Country (2023-2028) & (US$ Million)
Table 108. Medtronic Corporation Information
Table 109. Medtronic Description and Major Businesses
Table 110. Medtronic Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. Medtronic Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Medtronic Recent Developments
Table 113. Boston Scientific Corporation Information
Table 114. Boston Scientific Description and Major Businesses
Table 115. Boston Scientific Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Boston Scientific Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Boston Scientific Recent Developments
Table 118. Abbott Corporation Information
Table 119. Abbott Description and Major Businesses
Table 120. Abbott Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Abbott Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Abbott Recent Developments
Table 123. LivaNova Corporation Information
Table 124. LivaNova Description and Major Businesses
Table 125. LivaNova Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. LivaNova Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. LivaNova Recent Developments
Table 128. Nevro Corporation Information
Table 129. Nevro Description and Major Businesses
Table 130. Nevro Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Nevro Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Nevro Recent Developments
Table 133. NeuroPace Corporation Information
Table 134. NeuroPace Description and Major Businesses
Table 135. NeuroPace Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. NeuroPace Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. NeuroPace Recent Developments
Table 138. Beijing Pins Corporation Information
Table 139. Beijing Pins Description and Major Businesses
Table 140. Beijing Pins Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Beijing Pins Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Beijing Pins Recent Developments
Table 143. Synapse Biomedical Corporation Information
Table 144. Synapse Biomedical Description and Major Businesses
Table 145. Synapse Biomedical Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Synapse Biomedical Neuromodulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Synapse Biomedical Recent Developments
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Neuromodulation Devices Distributors List
Table 151. Neuromodulation Devices Customers List
Table 152. Neuromodulation Devices Market Trends
Table 153. Neuromodulation Devices Market Drivers
Table 154. Neuromodulation Devices Market Challenges
Table 155. Neuromodulation Devices Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuromodulation Devices Product Picture
Figure 3. Global Neuromodulation Devices Market Share by Type in 2021 & 2028
Figure 3. Deep Brain Stimulation (DBS) Product Picture
Figure 4. Spinal Cord Stimulation (SCS) Product Picture
Figure 5. Vagus Nerve Stimulation (VNS) Product Picture
Figure 6. Sacral Nerve Stimulation (SNS) Product Picture
Figure 7. Gastric Electrical Stimulation (GES) Product Picture
Figure 8. Global Neuromodulation Devices Market Share by Application in 2021 & 2028
Figure 9. Pain Management
Figure 10. Parkinsons Disease
Figure 11. Urinary and Fecal Incontinence
Figure 12. Epilepsy
Figure 13. Gastroparesis
Figure 14. Other
Figure 15. Neuromodulation Devices Report Years Considered
Figure 16. Global Neuromodulation Devices Sales 2017-2028 (K Units)
Figure 17. Global Neuromodulation Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Neuromodulation Devices Revenue 2017-2028 (US$ Million)
Figure 19. Global Neuromodulation Devices Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Neuromodulation Devices Sales Market Share by Region (2017-2022)
Figure 21. Global Neuromodulation Devices Sales Market Share by Region (2023-2028)
Figure 22. North America Neuromodulation Devices Sales YoY (2017-2028) & (K Units)
Figure 23. North America Neuromodulation Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Neuromodulation Devices Sales YoY (2017-2028) & (K Units)
Figure 25. Europe Neuromodulation Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Neuromodulation Devices Sales YoY (2017-2028) & (K Units)
Figure 27. Asia-Pacific Neuromodulation Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Neuromodulation Devices Sales YoY (2017-2028) & (K Units)
Figure 29. Latin America Neuromodulation Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Neuromodulation Devices Sales YoY (2017-2028) & (K Units)
Figure 31. Middle East & Africa Neuromodulation Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Neuromodulation Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Neuromodulation Devices in the World: Market Share by Neuromodulation Devices Revenue in 2021
Figure 34. Global Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 36. Global Neuromodulation Devices Revenue Market Share by Type (2017-2028)
Figure 37. Global Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 38. Global Neuromodulation Devices Revenue Market Share by Application (2017-2028)
Figure 39. North America Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 40. North America Neuromodulation Devices Revenue Market Share by Type (2017-2028)
Figure 41. North America Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 42. North America Neuromodulation Devices Revenue Market Share by Application (2017-2028)
Figure 43. North America Neuromodulation Devices Sales Share by Country (2017-2028)
Figure 44. North America Neuromodulation Devices Revenue Share by Country (2017-2028)
Figure 45. U.S. Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 48. Europe Neuromodulation Devices Revenue Market Share by Type (2017-2028)
Figure 49. Europe Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 50. Europe Neuromodulation Devices Revenue Market Share by Application (2017-2028)
Figure 51. Europe Neuromodulation Devices Sales Share by Country (2017-2028)
Figure 52. Europe Neuromodulation Devices Revenue Share by Country (2017-2028)
Figure 53. Germany Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 54. France Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Neuromodulation Devices Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Neuromodulation Devices Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Neuromodulation Devices Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Neuromodulation Devices Revenue Share by Region (2017-2028)
Figure 64. China Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 67. India Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 69. Taiwan Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 73. Philippines Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 75. Latin America Neuromodulation Devices Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 77. Latin America Neuromodulation Devices Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Neuromodulation Devices Sales Share by Country (2017-2028)
Figure 79. Latin America Neuromodulation Devices Revenue Share by Country (2017-2028)
Figure 80. Mexico Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Neuromodulation Devices Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Neuromodulation Devices Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Neuromodulation Devices Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Neuromodulation Devices Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Neuromodulation Devices Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Neuromodulation Devices Revenue Share by Country (2017-2028)
Figure 89. Turkey Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Neuromodulation Devices Revenue (2017-2028) & (US$ Million)
Figure 92. Neuromodulation Devices Value Chain
Figure 93. Neuromodulation Devices Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Buy
